Trial Details

COMPLETED
Basic Information
Clinical ID c790
Identifier NCT00048347
Trial Title Interferon-beta1a (AVONEX) Treatment of Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

YES

Conditions Ulcerative Colitis
Interventions DRUG: AVONEX
Participant Information
Sponsor National Institute of Allergy and Infectious Diseases (NIAID)
City Bethesda
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2025-10-02
Primary Completion Date 2025-06-08
Completion Date 2025-05-10